Skip to main content

Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.

Publication ,  Journal Article
Naga, HI; Mellia, JA; Basta, MN; Morris, MP; Christopher, AN; Campbell, FM; Sommers, K; Levinson, H; Nelson, JA; Fischer, JP
Published in: Plast Reconstr Surg
October 1, 2022

BACKGROUND: Although guidelines have been published on treatment of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), there has been no comprehensive analysis of BIA-ALCL treatment variation based on the available literature. The authors sought to assess current treatment strategies of BIA-ALCL relative to current guidelines. METHODS: Database searches were conducted in June of 2020. Included articles were case reports and case series with patient-level data. Collected variables included clinicopathologic features, implant characteristics, diagnostic tests, ALCL characteristics, treatment, and details of follow-up and outcome. Treatment data from before and after 2017 were compared with National Cancer Center Network guidelines. RESULTS: A total of 89 publications were included and 178 cases of BIA-ALCL were identified. Most patients presented with seroma ( n = 114, 70.4 percent), followed by a mass ( n = 14, 8.6 percent), or both ( n = 23, 14.2 percent). Treatment included en bloc capsulectomy of the affected implant in 122 out of 126 cases with treatment details provided (96.8 percent). Radiation therapy was given in 38 cases (30.2 percent) and chemotherapy was given in 71 cases (56.3 percent). Practitioners used less chemotherapy for local disease after treatment guideline publication in 2017 ( p < 0.001), whereas treatment for advanced disease remained unchanged ( p = 0.3). There were 10 recurrences and eight fatalities attributable to BIA-ALCL, which were associated with advanced presentation (29 versus 2.1 percent; OR, 19.4; 95 percent CI, 3.9 to 96.3; p < 0.001). CONCLUSIONS: BIA-ALCL remains a morbid but treatable condition. Current guidelines focus treatment for local disease and reduce nonsurgical interventions with radiation or chemotherapy. Patients presenting with advanced BIA-ALCL experience higher rates of recurrence and mortality.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Plast Reconstr Surg

DOI

EISSN

1529-4242

Publication Date

October 1, 2022

Volume

150

Issue

4

Start / End Page

762 / 769

Location

United States

Related Subject Headings

  • Surgery
  • Seroma
  • Lymphoma, Large-Cell, Anaplastic
  • Humans
  • Female
  • Breast Neoplasms
  • Breast Implants
  • Breast Implantation
  • 3203 Dentistry
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Naga, H. I., Mellia, J. A., Basta, M. N., Morris, M. P., Christopher, A. N., Campbell, F. M., … Fischer, J. P. (2022). Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies. Plast Reconstr Surg, 150(4), 762–769. https://doi.org/10.1097/PRS.0000000000009538
Naga, Hani I., Joseph A. Mellia, Marten N. Basta, Martin P. Morris, Adrienne N. Christopher, Frank M. Campbell, Katie Sommers, Howard Levinson, Jonas A. Nelson, and John P. Fischer. “Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.Plast Reconstr Surg 150, no. 4 (October 1, 2022): 762–69. https://doi.org/10.1097/PRS.0000000000009538.
Naga HI, Mellia JA, Basta MN, Morris MP, Christopher AN, Campbell FM, et al. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies. Plast Reconstr Surg. 2022 Oct 1;150(4):762–9.
Naga, Hani I., et al. “Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.Plast Reconstr Surg, vol. 150, no. 4, Oct. 2022, pp. 762–69. Pubmed, doi:10.1097/PRS.0000000000009538.
Naga HI, Mellia JA, Basta MN, Morris MP, Christopher AN, Campbell FM, Sommers K, Levinson H, Nelson JA, Fischer JP. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies. Plast Reconstr Surg. 2022 Oct 1;150(4):762–769.

Published In

Plast Reconstr Surg

DOI

EISSN

1529-4242

Publication Date

October 1, 2022

Volume

150

Issue

4

Start / End Page

762 / 769

Location

United States

Related Subject Headings

  • Surgery
  • Seroma
  • Lymphoma, Large-Cell, Anaplastic
  • Humans
  • Female
  • Breast Neoplasms
  • Breast Implants
  • Breast Implantation
  • 3203 Dentistry
  • 3202 Clinical sciences